ARCA biopharma Inc (ABIO)
3.625
-0.02
(-0.68%)
USD |
NASDAQ |
Apr 24, 16:00
3.625
0.00 (0.00%)
After-Hours: 20:00
ARCA biopharma Free Cash Flow (Quarterly): -1.056M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.056M |
| September 30, 2023 | -1.669M |
| June 30, 2023 | -0.694M |
| March 31, 2023 | -1.595M |
| December 31, 2022 | -1.494M |
| September 30, 2022 | -2.498M |
| June 30, 2022 | -2.622M |
| March 31, 2022 | -4.30M |
| December 31, 2021 | -4.954M |
| September 30, 2021 | -4.884M |
| June 30, 2021 | -3.736M |
| March 31, 2021 | -5.231M |
| December 31, 2020 | -3.008M |
| September 30, 2020 | -2.002M |
| June 30, 2020 | -1.045M |
| March 31, 2020 | -1.689M |
| December 31, 2019 | -1.16M |
| September 30, 2019 | -0.889M |
| June 30, 2019 | -1.19M |
| March 31, 2019 | -1.566M |
| December 31, 2018 | -1.343M |
| September 30, 2018 | -1.579M |
| June 30, 2018 | -2.254M |
| March 31, 2018 | -3.072M |
| December 31, 2017 | -4.197M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.974M |
| June 30, 2017 | -4.96M |
| March 31, 2017 | -4.344M |
| December 31, 2016 | -3.846M |
| September 30, 2016 | -3.742M |
| June 30, 2016 | -3.527M |
| March 31, 2016 | -3.884M |
| December 31, 2015 | -2.622M |
| September 30, 2015 | -2.404M |
| June 30, 2015 | -2.404M |
| March 31, 2015 | -3.115M |
| December 31, 2014 | -1.893M |
| September 30, 2014 | -2.077M |
| June 30, 2014 | -1.768M |
| March 31, 2014 | -3.687M |
| December 31, 2013 | -1.876M |
| September 30, 2013 | -1.687M |
| June 30, 2013 | -0.984M |
| March 31, 2013 | -0.773M |
| December 31, 2012 | -0.669M |
| September 30, 2012 | -0.775M |
| June 30, 2012 | -0.978M |
| March 31, 2012 | -1.656M |
| December 31, 2011 | -1.254M |
| September 30, 2011 | -1.676M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.231M
Minimum
Mar 2021
-0.694M
Maximum
Jun 2023
-2.406M
Average
-1.689M
Median
Mar 2020
Free Cash Flow (Quarterly) Benchmarks
| Shockwave Medical Inc | 63.58M |
| Asensus Surgical Inc | -13.45M |
| Glaukos Corp | -14.88M |
| Helius Medical Technologies Inc | -2.037M |
| Perspective Therapeutics Inc | -9.097M |